CREE
$92.26
Cree
$1.22
1.34%
Earnings Details
3rd Quarter March 2021
Wednesday, April 28, 2021 4:01:00 PM
Tweet Share Watch
Summary

Cree Provides Mixed Guidance

Cree (CREE) reported a 3rd Quarter March 2021 loss of $0.31 per share on revenue of $137.3 million. The consensus estimate was a loss of $0.31 per share on revenue of $130.2 million. Revenue fell 36.3% compared to the same quarter a year ago.

The company said it expects a fourth quarter non-GAAP loss of $0.26 to $0.22 per share on revenue of $142.0 million to $148.0 million. The current consensus estimate is a loss of $0.21 per share on revenue of $138.64 million for the quarter ending June 30, 2021.

Cree Inc manufactures lighting-class light emitting diode (LED) products, lighting products and semiconductor products for power and radio-frequency (RF) applications.

Results
Reported Earnings
($0.31)
Earnings Whisper
-
Consensus Estimate
($0.31)
Reported Revenue
$137.3 Mil
Revenue Estimate
$130.2 Mil
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

Cree Reports Financial Results for the Third Quarter of Fiscal Year 2021

DURHAM, N.C.--(BUSINESS WIRE)--Cree, Inc. (Nasdaq: CREE) today announced revenue from continuing operations of $137.3 million for its third quarter of fiscal 2021, ended March 28, 2021. This represents a 21% increase compared to revenue from continuing operations of $113.9 million reported for the third quarter of fiscal 2020, and an 8% increase compared to the second quarter of fiscal 2021. GAAP net loss from continuing operations for the third quarter of fiscal 2021 was $66.5 million, or $0.59 per diluted share, compared to GAAP net loss from continuing operations of $56.2 million, or $0.52 per diluted share, for the third quarter of fiscal 2020. On a non-GAAP basis, net loss from continuing operations for the third quarter of fiscal 2021 was $24.7 million, or $0.22 per diluted share, compared to non-GAAP net loss from continuing operations for the third quarter of fiscal 2020 of $18.4 million, or $0.17 per diluted share.

On March 1, 2021, Cree completed the previously announced sale of certain assets and subsidiaries comprising its former LED Products segment to SMART Global Holdings, Inc. (SGH) and its wholly owned acquisition subsidiary CreeLED, Inc. (CreeLED and collectively with SGH, SMART) for up to $300 million, including fixed upfront and deferred payments and contingent consideration.

“We are building solid momentum and during our fiscal third quarter we continued to execute and drive our strategy, delivering strong top line performance as customers continue to realize the benefits of silicon carbide,” said Cree CEO, Gregg Lowe. “With the sale of our LED business now complete, we accomplished a critical milestone in our journey to becoming a pure-play semiconductor powerhouse and have an even greater focus on converting opportunities in our pipeline and expanding our manufacturing capacity."

Business Outlook:

For its fourth quarter of fiscal 2021, Cree targets revenue in a range of $142 million to $148 million. GAAP net loss is targeted at $68 million to $73 million, or $0.59 to $0.63 per diluted share. Non-GAAP net loss is targeted to be in a range of $25 million to $30 million, or $0.22 to $0.26 per diluted share. Targeted non-GAAP net loss excludes $43 million of estimated expenses, net of tax, related to stock-based compensation expense, amortization or impairment of acquisition-related intangibles, factory optimization restructuring and start-up costs, net accretion on convertible notes and project, transformation, transaction and transition costs. The GAAP and non-GAAP targets do not include any estimated change in the fair value of Cree’s ENNOSTAR (formerly Lextar) investment, which was liquidated earlier this month.

Quarterly Conference Call:

Cree will host a conference call at 5:00 p.m. Eastern time today to review the highlights of the third quarter results and the fiscal fourth quarter 2021 business outlook, including significant factors and assumptions underlying the targets noted above.

The conference call will be available to the public through a live audio web broadcast via the Internet. For webcast details, visit Cree's website at investor.cree.com/events.cfm.

Supplemental financial information, including the non-GAAP reconciliation attached to this press release, is available on Cree's website at investor.cree.com/results.cfm.

About Cree, Inc.

Cree is an innovator of Wolfspeed® power and radio frequency (RF) semiconductors. Cree’s Wolfspeed product families include silicon carbide materials, power-switching devices and RF devices targeted for applications such as electric vehicles, fast charging inverters, power supplies, telecom and military and aerospace.

For additional product and Company information, please refer to www.cree.com.

Non-GAAP Financial Measures:

This press release highlights the Company's financial results on both a GAAP and a non-GAAP basis. The GAAP results include certain costs, charges and expenses that are excluded from non-GAAP results. By publishing the non-GAAP measures, management intends to provide investors with additional information to further analyze the Company's performance, core results and underlying trends. Cree's management evaluates results and makes operating decisions using both GAAP and non-GAAP measures included in this press release. Non-GAAP results are not prepared in accordance with GAAP and non-GAAP information should be considered a supplement to, and not a substitute for, financial statements prepared in accordance with GAAP. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures to their most directly comparable GAAP measures attached to this press release.

Presentation:

The Company revised income tax expense for the three months ended March 29, 2020 to correct the income tax provision calculation for the third quarter of fiscal 2020. The Company decreased income tax expense for the three months ended March 29, 2020, resulting in a net decrease to net loss of $1.5 million for the three months ended March 29, 2020. No revision was made to income tax expense for the nine months ended March 29, 2020. The Company concluded this error was not material individually or in the aggregate.

Forward Looking Statements:

The schedules attached to this release are an integral part of the release. This press release contains forward-looking statements involving risks and uncertainties, both known and unknown, that may cause Cree’s actual results to differ materially from those indicated in the forward-looking statements. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about our plans to grow the Wolfspeed business and our ability to achieve our targets for the fourth quarter of fiscal 2021. Actual results could differ materially due to a number of factors, including but not limited to, issues, delays or complications in completing required transition activities to allow the LED Products business to operate under the SMART portfolio of businesses after the closing, including incurring unanticipated costs to complete such activities; risks relating to the COVID-19 pandemic, the risk of new and different government restrictions that limit our ability to do business, the risk of infection in our workforce and subsequent impact on our ability to conduct business, the risk that our supply chain or customer demand may continue to be negatively impacted, the risk that the COVID-19 pandemic will lead to a global recession and the potential for costs associated with our operations during the fiscal 2021 fourth quarter and future quarters to be greater than we anticipate as a result of all of these factors; the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs, lower yields and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; product mix; risks associated with the ramp-up of production of our new products, and our entry into new business channels different from those in which we have historically operated; risks associated with our factory optimization plan and construction of a new fabrication facility, including design and construction delays and cost overruns, issues in installing and qualifying new equipment and ramping production, poor production process yields and quality control, and potential increases to our restructuring costs; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that the economic and political uncertainty caused by the tariffs imposed by the United States on Chinese goods, and corresponding Chinese tariffs and currency devaluation in response, may negatively impact demand for our products; risks related to international sales and purchases, including the risk that U.S. government actions with respect to Huawei Technologies Co. and its affiliates or other foreign customers or vendors may have a greater impact on our business and results of operations than our expectations; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our remaining goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs; risks associated with strategic transactions, including the possibility that we may not realize the full purchase price contemplated in connection with the sale of our former LED Products or Lighting Products business units; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10-K for the fiscal year ended June 28, 2020, and subsequent reports filed with the SEC. These forward-looking statements represent Cree's judgment as of the date of this release. Except as required under the U.S. federal securities laws and the rules and regulations of the SEC, Cree disclaims any intent or obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events, developments, changes in assumptions or otherwise.

Cree® and Wolfspeed® are registered trademarks of Cree, Inc.

 

CREE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

 

Three months ended

 

Nine months ended

(in millions of U.S. Dollars, except per share data)

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

Revenue, net

$137.3

 

 

$113.9

 

 

$379.8

 

 

$362.3

 

Cost of revenue, net

93.3

 

 

72.6

 

 

259.0

 

 

232.9

 

Gross profit

44.0

 

 

41.3

 

 

120.8

 

 

129.4

 

Gross margin percentage

32

%

 

36

%

 

32

%

 

36

%

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Research and development

46.0

 

 

38.6

 

 

132.7

 

 

112.5

 

Sales, general and administrative

44.2

 

 

41.7

 

 

135.0

 

 

135.7

 

Amortization or impairment of acquisition-related intangibles

3.7

 

 

3.7

 

 

10.9

 

 

10.9

 

Loss on disposal or impairment of other assets

0.1

 

 

0.1

 

 

0.8

 

 

1.7

 

Other operating expense

11.4

 

 

5.2

 

 

22.6

 

 

22.2

 

Operating loss

(61.4)

 

 

(48.0)

 

 

(181.2)

 

 

(153.6)

 

Operating loss percentage

(45)

%

 

(42)

%

 

(48)

%

 

(42)

%

 

 

 

 

 

 

 

 

Non-operating expense, net

8.1

 

 

14.7

 

 

18.9

 

 

8.1

 

Loss before income taxes

(69.5)

 

 

(62.7)

 

 

(200.1)

 

 

(161.7)

 

Income tax benefit

(3.0)

 

 

(6.5)

 

 

(4.0)

 

 

(8.3)

 

Net loss from continuing operations

(66.5)

 

 

(56.2)

 

 

(196.1)

 

 

(153.4)

 

Net (loss) income from discontinued operations

(41.6)

 

 

(3.7)

 

 

(178.8)

 

 

1.7

 

Net loss

(108.1)

 

 

(59.9)

 

 

(374.9)

 

 

(151.7)

 

Net income from discontinued operations attributable to noncontrolling interest

0.8

 

 

0.2

 

 

1.4

 

 

0.5

 

Net loss attributable to controlling interest

($108.9)

 

 

($60.1)

 

 

($376.3)

 

 

($152.2)

 

 

 

 

 

 

 

 

 

Basic and diluted loss per share

 

 

 

 

 

 

 

Continuing operations

($0.59)

 

 

($0.52)

 

 

($1.75)

 

 

($1.42)

 

Net loss attributable to controlling interest

($0.96)

 

 

($0.56)

 

 

($3.35)

 

 

($1.41)

 

 

 

 

 

 

 

 

 

Weighted average shares - basic and diluted (in thousands)

112,891

 

 

108,115

 

 

112,330

 

 

107,718

 

 

CREE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

 

(in millions of U.S. Dollars)

March 28, 2021

 

June 28, 2020

Assets

 

 

 

Current assets:

 

 

 

Cash, cash equivalents, and short-term investments

$1,293.3

 

 

$1,239.7

 

Accounts receivable, net

84.1

 

 

72.4

 

Inventories

147.5

 

 

121.9

 

Income taxes receivable

9.1

 

 

6.6

 

Prepaid expenses

23.8

 

 

26.2

 

Other current assets

38.5

 

 

8.7

 

Current assets held for sale

2.0

 

 

1.3

 

Current assets of discontinued operations

 

 

116.0

 

Total current assets

1,598.3

 

 

1,592.8

 

Property and equipment, net

1,165.1

 

 

770.8

 

Goodwill

359.2

 

 

349.7

 

Intangible assets, net

144.6

 

 

156.9

 

Long-term receivables

137.8

 

 

 

Other long-term investments

67.2

 

 

55.9

 

Deferred tax assets

1.2

 

 

1.2

 

Other assets

33.0

 

 

33.6

 

Long-term assets of discontinued operations

1.3

 

 

270.1

 

Total assets

$3,507.7

 

 

$3,231.0

 

 

 

 

 

Liabilities and Shareholders' Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable and accrued expenses

$319.5

 

 

$189.8

 

Accrued contract liabilities

24.5

 

 

14.2

 

Income taxes payable

 

 

1.2

 

Finance lease liabilities

0.4

 

 

3.6

 

Other current liabilities

37.8

 

 

22.2

 

Current liabilities of discontinued operations

0.6

 

 

60.2

 

Total current liabilities

382.8

 

 

291.2

 

 

 

 

 

Long-term liabilities:

 

 

 

Convertible notes, net

813.7

 

 

783.8

 

Deferred tax liabilities

2.3

 

 

1.8

 

Finance lease liabilities - long-term

10.1

 

 

11.4

 

Other long-term liabilities

51.1

 

 

43.8

 

Long-term liabilities of discontinued operations

0.7

 

 

9.8

 

Total long-term liabilities

877.9

 

 

850.6

 

 

 

 

 

Shareholders’ equity:

 

 

 

Common stock

0.1

 

 

0.1

 

Additional paid-in-capital

3,658.9

 

 

3,106.2

 

Accumulated other comprehensive income

3.5

 

 

16.0

 

Accumulated deficit

(1,415.5)

 

 

(1,039.2)

 

Total shareholders’ equity

2,247.0

 

 

2,083.1

 

Noncontrolling interest from discontinued operations

 

 

6.1

 

Total equity

2,247.0

 

 

2,089.2

 

Total liabilities and shareholders’ equity

$3,507.7

 

 

$3,231.0

 

 

CREE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

 

Nine months ended

(in millions of U.S. Dollars)

March 28, 2021

 

March 29, 2020

Operating activities:

 

 

 

Net loss

($374.9)

 

 

($151.7)

 

Net (loss) income from discontinued operations

(178.8)

 

 

1.7

 

Net loss from continuing operations

(196.1)

 

 

(153.4)

 

Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:

 

 

 

Depreciation and amortization

88.6

 

 

73.7

 

Amortization of debt issuance costs and discount, net of capitalized interest

26.1

 

 

17.2

 

Stock-based compensation

40.3

 

 

36.9

 

Loss on disposal or impairment of long-lived assets

3.7

 

 

1.7

 

Amortization of premium/discount on investments

4.9

 

 

0.5

 

Realized gain on sale of investments

(0.3)

 

 

(1.0)

 

(Gain) loss on equity investment

(7.9)

 

 

9.2

 

Foreign exchange gain on equity investment

(3.4)

 

 

(1.2)

 

Deferred income taxes

0.5

 

 

(0.8)

 

Changes in operating assets and liabilities:

 

 

 

Accounts receivable, net

(11.7)

 

 

(31.7)

 

Inventories

(25.4)

 

 

2.2

 

Prepaid expenses and other assets

(28.2)

 

 

0.9

 

Accounts payable, trade

27.2

 

 

(6.3)

 

Accrued salaries and wages and other liabilities

12.5

 

 

(18.7)

 

Accrued contract liabilities

10.3

 

 

5.9

 

Net cash used in operating activities of continuing operations

(58.9)

 

 

(64.9)

 

Net cash (used in) provided by operating activities of discontinued operations

(16.6)

 

 

25.4

 

Cash used in operating activities

(75.5)

 

 

(39.5)

 

 

 

 

 

Investing activities:

 

 

 

Purchases of property and equipment

(394.0)

 

 

(166.9)

 

Purchases of patent and licensing rights

(3.6)

 

 

(2.8)

 

Proceeds from sale of property and equipment

0.2

 

 

1.8

 

Purchases of short-term investments

(342.1)

 

 

(421.2)

 

Proceeds from maturities of short-term investments

335.6

 

 

342.5

 

Proceeds from sale of short-term investments

28.1

 

 

96.4

 

Proceeds from sale of business, net

36.6

 

 

 

Net cash used in investing activities of continuing operations

(339.2)

 

 

(150.2)

 

Net cash used in investing activities of discontinued operations

(0.3)

 

 

(2.0)

 

Cash used in investing activities

(339.5)

 

 

(152.2)

 

 

 

 

 

Financing activities:

 

 

 

Proceeds from long-term debt borrowings

30.0

 

 

 

Payments on long-term debt borrowings, including finance lease obligations

(30.3)

 

 

(0.4)

 

Proceeds from issuance of common stock

530.1

 

 

31.0

 

Tax withholding on vested equity awards

(31.7)

 

 

(16.2)

 

Commitment fee on long-term incentive agreement

(0.5)

 

 

 

Cash provided by financing activities

497.6

 

 

14.4

 

Effects of foreign exchange changes on cash and cash equivalents

0.2

 

 

(0.2)

 

Net change in cash and cash equivalents

82.8

 

 

(177.5)

 

Cash and cash equivalents:

 

 

 

Cash and cash equivalents, beginning of period

448.8

 

 

500.5

 

Cash and cash equivalents, end of period

$531.6

 

 

$323.0

 

Cree, Inc.
Non-GAAP Measures of Financial Performance

To supplement the Company's consolidated financial statements presented in accordance with generally accepted accounting principles, or GAAP, Cree uses non-GAAP measures of certain components of financial performance. These non-GAAP measures include non-GAAP gross margin, non-GAAP operating (loss) income, non-GAAP non-operating income (expense), net, non-GAAP net (loss) income, non-GAAP diluted (loss) earnings per share from continuing operations and free cash flow.

Reconciliation to the nearest GAAP measure of all historical non-GAAP measures included in this press release can be found in the tables included with this press release. Both our GAAP targets and non-GAAP targets do not include any estimated changes in the fair value of our ENNOSTAR (formerly Lextar) investment, which was liquidated earlier this month.

Non-GAAP measures presented in this press release are not in accordance with or an alternative to measures prepared in accordance with GAAP and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with Cree's results of operations as determined in accordance with GAAP. These non-GAAP measures should only be used to evaluate Cree's results of operations in conjunction with the corresponding GAAP measures.

Cree believes that these non-GAAP measures, when shown in conjunction with the corresponding GAAP measures, enhance investors' and management's overall understanding of the Company's current financial performance and the Company's prospects for the future, including cash flows available to pursue opportunities to enhance shareholder value. In addition, because Cree has historically reported certain non-GAAP results to investors, the Company believes the inclusion of non-GAAP measures provides consistency in the Company's financial reporting.

For its internal budgeting process, and as discussed further below, Cree's management uses financial statements that do not include the items listed below and the income tax effects associated with the foregoing. Cree's management also uses non-GAAP measures, in addition to the corresponding GAAP measures, in reviewing the Company's financial results.

Cree excludes the following items from one or more of its non-GAAP measures when applicable:

Stock-based compensation expense. This expense consists of expenses for stock options, restricted stock, performance stock awards and employee stock purchases through its Employee Stock Purchase Program. Cree excludes stock-based compensation expenses from its non-GAAP measures because they are non-cash expenses that Cree does not believe are reflective of ongoing operating results.

Amortization or impairment of acquisition-related intangibles. Cree incurs amortization or impairment of acquisition-related intangibles in connection with acquisitions. Cree excludes these items because they arise from Cree's prior acquisitions and have no direct correlation to the ongoing operating results of Cree's business.

Factory optimization restructuring. In May 2019, the Company started a significant, multi-year factory optimization plan to be anchored by a state-of-the-art, automated 200mm silicon carbide fabrication facility. In September 2019, the Company announced the intent to build the new fabrication facility in Marcy, New York to complement the factory expansion underway at its U.S. campus headquarters in Durham, North Carolina. As part of the plan, the Company will incur restructuring costs associated with the movement of equipment as well as disposals on certain long-lived assets. Because these charges relate to assets which had been retired prior to the end of their estimated useful lives, Cree does not believe these costs are reflective of ongoing operating results. Similarly, Cree does not consider the realized net losses on sale of assets relating to the restructuring to be reflective of ongoing operating results.

Severance and other restructuring. These costs relate to the Company's realignment of certain resources as part of the Company's transition to a more focused semiconductor company. Cree does not believe these costs are reflective of ongoing operating results.

Project, transformation and transaction costs. The Company has incurred professional services fees and other costs associated with completed and potential acquisitions and divestitures, as well as internal transformation programs focused on optimizing the Company's administrative processes. Cree excludes these items because Cree believes they are not reflective of the ongoing operating results of Cree's business.

Factory optimization start-up costs. The Company has incurred and will incur start-up costs as part of the factory optimization plan. Cree does not believe these costs are reflective of ongoing operating results.

Non-restructuring related executive severance. The Company has incurred costs in conjunction with the termination of key executive personnel. Cree excludes these items because Cree believes they have no direct correlation to the ongoing operating results of Cree's business.

Transition service agreement costs. As a result of the sale of the Lighting Products business unit, the Company is providing certain information technology services under a transition services agreement which will not be reimbursed. Cree excludes the costs of these services because Cree believes they are not reflective of the ongoing operating results of Cree's business.

Asset impairment. In fiscal 2020, the Company incurred impairment charges in conjunction with the sale of the Lighting Products business unit for assets excluded from the purchase agreement. Cree excludes these items because Cree believes they are not reflective of the ongoing operating results of Cree's business.

Net changes in fair value of our ENNOSTAR (formerly Lextar) investment. In January 2021, Lextar Electronics Corporation (Lextar) completed its previously announced restructuring under a holding company named ENNOSTAR Inc. (ENNOSTAR) with EPISTAR Corporation via a share swap pursuant to which the Company received 0.275 shares of common stock of ENNOSTAR for each of share of Lextar common stock. The Company's common stock ownership investment in ENNOSTAR is accounted for utilizing the fair value option. As such, changes in fair value are recognized in income, including fluctuations due to the exchange rate between the New Taiwan Dollar and the United States Dollar. Cree excludes the impact of these gains or losses from its non-GAAP measures because they are non-cash impacts that Cree does not believe are reflective of ongoing operating results. Additionally, Cree excludes the impact of dividends received on its ENNOSTAR investment as Cree does not believe it is reflective of ongoing operating results. From March 29, 2021 to April 16, 2021, the Company liquidated its common stock ownership interest in ENNOSTAR.

Gain on arbitration proceedings. In the third quarter of fiscal 2020, the Company won an arbitration proceeding for which we were awarded damages for a claim by us against a contract manufacturer. The arbitration victory resulted in a cash settlement beyond the legal fees incurred and was recognized as a gain in other income. Cree excludes this item because Cree believes it is not reflective of the ongoing operating results of Cree's business.

Accretion on convertible notes, net of capitalized interest. The issuance of the Company's convertible senior notes in August 2018 and April 2020 results in interest accretion on the convertible notes' issue costs and discount. Cree considers these items as either limited in term or having no impact on the Company's cash flows, and therefore has excluded such items to facilitate a review of current operating performance and comparisons to the Company's past operating performance.

Loss on Wafer Supply Agreement. In connection with the completed sale of the LED Products business unit to SMART, the Company entered into a Wafer Supply and Fabrication Services Agreement (the Wafer Supply Agreement), pursuant to which the Company will supply CreeLED with certain silicon carbide materials and fabrication services for up to four years. Cree excludes the financial impact of this agreement because Cree believes it is not reflective of the ongoing operating results of Cree's business.

Income tax adjustment. This amount reconciles GAAP tax (benefit) expense to a calculated non-GAAP tax (benefit) expense utilizing a non-GAAP tax rate. The non-GAAP tax rate estimates an appropriate tax rate if the listed non-GAAP items were excluded. This reconciling item adjusts non-GAAP net (loss) income to the amount it would be if the calculated non-GAAP tax rate was applied to non-GAAP (loss) income before taxes.

Cree may incur some of these same expenses, including income taxes associated with these expenses, in future periods. In addition to the non-GAAP measures discussed above, Cree also uses free cash flow as a measure of operating performance and liquidity. Free cash flow represents operating cash flows from continuing operations less net purchases of property and equipment and patent and licensing rights. Cree considers free cash flow to be an operating performance and a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business after the purchases of property and equipment, a portion of which can then be used to, among other things, invest in Cree's business, make strategic acquisitions and strengthen the balance sheet. A limitation of the utility of free cash flow as a measure of operating performance and liquidity is that it does not represent the residual cash flow available to the company for discretionary expenditures, as it excludes certain mandatory expenditures such as debt service.

 

CREE, INC.

Reconciliation of GAAP to Non-GAAP Measures

(in millions of U.S. Dollars, except per share amounts and percentages)

(unaudited)

 

Non-GAAP Gross Margin

 

Three months ended

 

Nine months ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

GAAP gross profit

$44.0

 

 

$41.3

 

 

$120.8

 

 

$129.4

 

GAAP gross margin percentage

32

%

 

36

%

 

32

%

 

36

%

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation expense

4.1

 

 

2.7

 

 

11.2

 

 

7.1

 

Factory optimization restructuring

 

 

 

 

1.0

 

 

 

Non-GAAP gross profit

$48.1

 

 

$44.0

 

 

$133.0

 

 

$136.5

 

Non-GAAP gross margin percentage

35

%

 

39

%

 

35

%

 

38

%

Non-GAAP Operating Loss

 

Three months ended

 

Nine months ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

GAAP operating loss

($61.4)

 

 

($48.0)

 

 

($181.2)

 

 

($153.6)

 

GAAP operating loss percentage

(45)

%

 

(42)

%

 

(48)

%

 

(42)

%

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation expense:

 

 

 

 

 

 

 

Cost of revenue, net

4.1

 

 

2.7

 

 

11.2

 

 

7.1

 

Research and development

2.1

 

 

1.9

 

 

6.7

 

 

6.0

 

Sales, general and administrative

6.7

 

 

5.2

 

 

22.4

 

 

23.8

 

Total stock-based compensation expense

12.9

 

 

9.8

 

 

40.3

 

 

36.9

 

Amortization or impairment of acquisition-related intangibles

3.7

 

 

3.7

 

 

10.9

 

 

10.9

 

Factory optimization restructuring

3.8

 

 

1.1

 

 

7.7

 

 

3.5

 

Severance and other restructuring

0.6

 

 

 

 

3.4

 

 

0.8

 

Project, transformation and transaction costs

3.7

 

 

1.4

 

 

6.7

 

 

10.8

 

Factory optimization start-up costs

1.8

 

 

2.1

 

 

6.0

 

 

5.0

 

Non-restructuring related executive severance

2.8

 

 

0.6

 

 

2.8

 

 

2.1

 

Transition service agreement costs

0.1

 

 

2.5

 

 

5.0

 

 

10.7

 

Asset impairment

 

 

 

 

 

 

0.2

 

Non-GAAP operating loss

($32.0)

 

 

($26.8)

 

 

($98.4)

 

 

($72.7)

 

Non-GAAP operating loss percentage

(23)

%

 

(24)

%

 

(26)

%

 

(20)

%

Non-GAAP Non-Operating (Expense) Income, net

 

Three months ended

 

Nine months ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

GAAP non-operating expense, net

($8.1)

 

 

($14.7)

 

 

($18.9)

 

 

($8.1)

 

Adjustments:

 

 

 

 

 

 

 

Net changes in the fair value of ENNOSTAR (formerly Lextar) investment

(1.1)

 

 

19.2

 

 

(11.3)

 

 

8.0

 

Gain on arbitration proceedings

 

 

(8.0)

 

 

 

 

(8.0)

 

Accretion on convertible notes, net of capitalized interest

8.0

 

 

5.8

 

 

26.1

 

 

17.2

 

Loss on Wafer Supply Agreement

0.1

 

 

 

 

0.1

 

 

 

Non-GAAP non-operating (expense) income, net

($1.1)

 

 

$2.3

 

 

($4.0)

 

 

$9.1

 

Non-GAAP Net Loss

 

Three months ended

 

Nine months ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

GAAP net loss from continuing operations

($66.5)

 

 

($56.2)

 

 

($196.1)

 

 

($153.4)

 

Adjustments:

 

 

 

 

 

 

 

Stock-based compensation expense

12.9

 

 

9.8

 

 

40.3

 

 

36.9

 

Amortization or impairment of acquisition-related intangibles

3.7

 

 

3.7

 

 

10.9

 

 

10.9

 

Factory optimization restructuring

3.8

 

 

1.1

 

 

7.7

 

 

3.5

 

Severance and other restructuring

0.6

 

 

 

 

3.4

 

 

0.8

 

Project, transformation and transaction costs

3.7

 

 

1.4

 

 

6.7

 

 

10.8

 

Factory optimization start-up costs

1.8

 

 

2.1

 

 

6.0

 

 

5.0

 

Non-restructuring related executive severance

2.8

 

 

0.6

 

 

2.8

 

 

2.1

 

Transition service agreement costs

0.1

 

 

2.5

 

 

5.0

 

 

10.7

 

Asset impairment

 

 

 

 

 

 

0.2

 

Net changes in the fair value of ENNOSTAR (formerly Lextar) investment

(1.1)

 

 

19.2

 

 

(11.3)

 

 

8.0

 

Gain on arbitration proceedings

 

 

(8.0)

 

 

 

 

(8.0)

 

Accretion on convertible notes, net of capitalized interest

8.0

 

 

5.8

 

 

26.1

 

 

17.2

 

Loss on Wafer Supply Agreement

0.1

 

 

 

 

0.1

 

 

 

Total adjustments to GAAP net loss from continuing operations before provision for income taxes

36.4

 

 

38.2

 

 

97.7

 

 

98.1

 

Income tax adjustment - benefit (expense)

5.4

 

 

(0.4)

 

 

20.6

 

 

7.6

 

Non-GAAP net loss from continuing operations

($24.7)

 

 

($18.4)

 

 

($77.8)

 

 

($47.7)

 

 

 

 

 

 

 

 

 

Non-GAAP diluted loss per share from continuing operations

($0.22)

 

 

($0.17)

 

 

($0.69)

 

 

($0.44)

 

Non-GAAP weighted average shares (in thousands)

112,891

 

 

108,115

 

 

112,330

 

 

107,718

 

Free Cash Flow

 

Three months ended

 

Nine months ended

 

March 28, 2021

 

March 29, 2020

 

March 28, 2021

 

March 29, 2020

Net cash used in operating activities from continuing operations

($26.8)

 

 

($25.3)

 

 

($58.9)

 

 

($64.9)

 

Less: PP&E spending

(136.5)

 

 

(66.6)

 

 

(394.0)

 

 

(166.9)

 

Less: Patents spending

(1.7)

 

 

(1.4)

 

 

(3.6)

 

 

(2.8)

 

Total free cash flow

($165.0)

 

 

($93.3)

 

 

($456.5)

 

 

($234.6)

 

 

CREE, INC.

Business Outlook Unaudited GAAP to Non-GAAP Reconciliation

 

 

 

Three Months Ended

(in millions of U.S. Dollars)

 

June 27, 2021

GAAP net loss outlook range

 

($73) to ($68)

Adjustments:

 

 

Stock-based compensation expense

 

13

Amortization or impairment of acquisition-related intangibles

 

4

Factory optimization restructuring and start-up costs

 

5

Accretion on convertible notes, net of capitalized interest

 

8

Project, transformation, transaction and transition costs

 

1

Total adjustments to GAAP net loss before provision for income taxes

 

31

Income tax adjustment

 

12

Non-GAAP net loss outlook range

 

($30) to ($25)

 

Tyler Gronbach
Cree, Inc.
Vice President, Investor Relations
Phone: 919-407-4820
investorrelations@cree.com

Source: Cree, Inc.